Cascador Health bridges the gap between data sources and the users of healthcare data.
Every time a patient is treated, healthcare providers collect data. The use - and thus value - of these data beyond patient diagnosis and treatment rose exponentially since hospitals started digitally archiving patient data in the nineties. At first, these historic patient data records were seen as a useful tool for internal processes (billing, patient follow-up etc). Today, it is clear that these Real World Data (RWD) are an invaluable asset for many stakeholders. They allow for profound insights in therapeutic outcomes, better site selection for clinical studies, monitoring safety and adverse effects, or simply help optimise processes in hospitals. Overall, they contribute to better healthcare.
Nonetheless, the valorization of RWD is currently not a priority for healthcare providers and well below its potential. Obstacles include fear of public opinion, fear of infringement of (privacy) laws, being confronted with data with insufficiencies (quality, quantity), the technical complexity of extracting and upcycling data,…
This is where Cascador Health comes into play. Cascador Health bridges the gap between sources and users of healthcare data. The company unravels the inherent complexity of patient data valorization by taking away technical and governance hurdles. It supports healthcare providers in retrieving patient data across their many IT systems and interfaces, and provides life sciences with curated, validated and anonymised RWD. By enabling both parties to gain insights, Cascador allows healthcare providers and life science industry to gain insights and provide better care.
Aphea.Bio is developing the next generation of agricultural biologicals.
Obulytix develops the next generation of enzyme-based antibiotics inspired by nature.